AFFX : Analysis & Opinions

  1. Integra Lifesciences Up on Launch of Bilayer Skin Product - ...

    December 19, 2014
    This latest single-use skin product of Integra (IART) is at present the only pre-meshed bilayer matrix that has been approved ...
  2. Bruker Unveils bioAFM System for High Resolution Imaging - Analyst ...

    December 18, 2014
    Bruker's (BRKR) BioScope Resolve provides real-time correlation of atomic force microscopy and optical microscopy data sets
  3. Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst ...

    December 16, 2014
    On Dec 10, 2014, we issued an updated research report on Illumina Inc. (ILMN).
  4. Genomic Health's Breast Cancer Test Yields Positive Results - ...

    December 16, 2014
    Oncotype DX breast cancer test ??? as Genomic Health's (GHDX) first product ??? has been an important contributor to U.S. ...
  5. Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - ...

    December 15, 2014
    Jazz Pharmaceuticals (JAZZ) has started the rolling submission of a NDA for defibrotide.
  6. Bull of the Day: Affymetrix (AFFX) - Bull of the Day

    November 5, 2014
    Bull of the Day: Affymetrix (AFFX) - Bull of the Day
  7. Bull of the Day: Affymetrix (AFFX) - Bull of the Day

    June 25, 2014
    Bull of the Day: Affymetrix (AFFX) - Bull of the Day
  8. Bull of the Day: Affymetrix (AFFX) - Bull of the Day

    January 10, 2014
    Bull of the Day: Affymetrix (AFFX) - Bull of the Day
  9. R&D The Future For Life Sciences Equipment Firms

    September 20, 2011
    Finding new healthcare solutions will be a paramount concern going forward. For investors, the best way to profit from this ...
  10. Affymetrix's Downward Spiral Continues

    July 7, 2011
    Affymetrix continues to flounder with unexciting technology.
  11. Illumina Lights Up Again

    April 29, 2011
    Illumina is a torrid grower, and growth investors seem to be willing to pay any price.
  12. Big Pharma's Big Problem

    August 16, 2010
    Big Pharma's best patents are expiring, but it may be able to reinvent itself through acquisitions.
  13. Affymetrix Misses Revenue Again And Again

    October 16, 2008
    Affymetrix missed revenue for the third consecutive quarter and blamed weak sales on a weak market - something competitors ...
Trading Center